TNBI OTC
Tanke Biosciences Corporation
1W: +0.0%
1M: -50.0%
3M: -50.0%
YTD: -66.7%
1Y: -80.0%
3Y: -87.5%
5Y: -99.2%
$0.01
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$977
+88.5% ▲
Operating Income
-$117K
-24.7% ▼
Net Income
-$120K
-45.3% ▼
EPS (Diluted)
$-0.00
-20.5% ▼
EBITDA
-$116K
-538.0% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2012 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $29M | $0 | $0 | $0 | $0 |
| YoY Growth | +19.8% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $19M | $0 | $0 | $8K | $978 |
| Gross Profit | $10M | $0 | $0 | -$8K | -$977 |
| Gross Margin | 34.8% | — | — | — | — |
| R&D Expenses | $291K | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5M | $668K | $128K | $86K | $116K |
| Operating Expenses | $5M | $668K | $128K | $86K | $116K |
| Operating Income | $5M | -$668K | -$128K | -$94K | -$117K |
| Operating Margin | 15.9% | — | — | — | — |
| Interest Expense | $1M | $2K | $56K | $56K | $908 |
| Income Before Tax | $603K | -$723K | -$98K | -$83K | -$120K |
| Tax Expense | $832K | $0 | $0 | $0 | $0 |
| Net Income | -$210K | -$723K | -$98K | -$83K | -$120K |
| Net Margin | -0.7% | — | — | — | — |
| EPS (Diluted) | $-0.02 | $-0.06 | $-0.01 | $-0.00 | $-0.00 |
| EBITDA | $5M | -$55K | $30K | -$18K | -$116K |
| Shares Outstanding | 13M | 13M | 12M | 21M | 25M |